Hospital Parc Tauli

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Osteoarthritis2 trials
• Brain aneurysm1 trial
• Coronary artery disease1 trial
• Dilated cardiomyopathy1 trial
• Gaucher disease1 trial
• Glioblastoma1 trial
• Heart failure1 trial
• Kidney cancer1 trial
• Liver cirrhosis1 trial
• Multiple myeloma1 trial
• Peripheral artery disease1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting4 trials
• Completed3 trials
• Active, not recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Consorcio Centro de Investigación Biomédica en Red (CIBER)1 trial
• Corporacion Parc Tauli1 trial
• Fundacion Clinic per a la Recerca Biomédica1 trial
• Fundación EPIC1 trial
• Fundación Española de Hematología y Hemoterapía1 trial
• and 5 more

Running trials

• Recruiting

  Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology

  NCT06603831· Corporacion Parc Tauli· Source

  Contact: Mireia Montserrat Viñas

• Recruiting

  Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patients With Cerebral Aneurysms Using P64 and P48 Flow-Diverter Stents

  NCT06201598· Hospital Universitario Central de Asturias· Source

  Contact: PEDRO VEGA VALDES, MD, PhD

• Recruiting

  Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)

  NCT06055504· Consorcio Centro de Investigación Biomédica en Red (CIBER)· Source

  Contact: Amadeo Marcelo Rizzo (principal investigator)

• Recruiting

  GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma

  NCT05992532· Fundación Española de Hematología y Hemoterapía· Source

  Contact: Marta Gomez Nuñez, MD

• Recruiting

  SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

  NCT05617599· Fundación EPIC· Source

  Contact: Bruno Garcia, MD, PhD

• Active, not recruiting

  LAM561 With RT and TMZ for Adults With Glioblastoma

  NCT04250922· Phase 2/3· Laminar Pharmaceuticals· Source

• Active, not recruiting

  Zimmer POLAR Persona - TKA (EMEA Study)

  NCT02337244· Zimmer, GmbH· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Brain aneurysm1 recruiting
• Coronary artery disease1 recruiting
• Dilated cardiomyopathy1 recruiting
• Gaucher disease1 recruiting
• Heart failure1 recruiting
• Multiple myeloma1 recruiting
• Osteoarthritis1 recruiting

Closed trials

• Completed

  Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma

  NCT07354282· Spanish Oncology Genito-Urinary Group· Source

• Completed

  Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease

  NCT05192616· iVascular S.L.U.· Source

• Completed

  Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)

  NCT03941405· Phase 2· Fundacion Clinic per a la Recerca Biomédica· Source